Vol 12, No 1 (January 31, 2023): Translational Lung Cancer Research

Original Article

Circulating immune response proteins predict the outcome following disease progression of osimertinib treated epidermal growth factor receptor-positive non-small-cell lung cancer patients
Christoffer T. Maansson, Sofie Helstrup, Eva B. F. Ebert, Peter Meldgaard, Boe S. Sorensen
BRAF RNA is prognostic and widely expressed in lung adenocarcinoma
David Dora, Imre Vörös, Zoltán V. Varga, Peter Takacs, Vanda Teglasi, Judit Moldvay, Zoltan Lohinai
Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR/Cas9-mediated gene-disruptions corroborate the MIR141/MIR200C-ZEB1/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistance in NSCLC cells
Johan Vad-Nielsen, Nicklas Heine Staunstrup, Magnus Lindkvist Kjeldsen, Nina Dybdal, Guillaume Flandin, Claudia De Stradis, Tina Fuglsang Daugaard, Trine Vilsbøll-Larsen, Christoffer Trier Maansson, Thomas Koed Doktor, Boe Sandahl Sorensen, Anders Lade Nielsen
Effect of histology on stereotactic body radiotherapy for non-small cell lung cancer oligometastatic pulmonary lesions
Alexander J. Allen, Dominic A. Labella, Roman O. Kowalchuk, Michael R. Waters, Charles R. Kersh
The association between clinical parameters and resectability in stage III non-small cell lung cancer, and a combination of N2 lymph node burden and lung immune prognostic index score as a potential biomarker
Seohyun Kim, Jeong Uk Lim, Hye Seon Kang, Ah Young Shin, Chang Dong Yeo, Sung Kyoung Kim, Chan Kwon Park, Seung Joon Kim, Sang Haak Lee, Jin Woo Kim
Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort study
Qi-Hua Zou, Hui Liu, Cai-Wen Huang, Li-Ping Kang, Bo Qiu, Jian-Liang Mai, Yong-Bin Lin, Ying Liang
Gene expression profiling of circulating tumor cells captured by MicroCavity Array is superior to enumeration in demonstrating therapy response in patients with newly diagnosed advanced and locally advanced non-small cell lung cancer
Evan N. Cohen, Gitanjali Jayachandran, Hui Gao, Phillip Peabody, Heather B. McBride, Franklin D. Alvarez, Pablo Lopez Bravo, Wei Qiao, Suyu Liu, Luyang Yao, Steven H. Lin, James M. Reuben
Effectiveness and safety of camrelizumab in inoperable or advanced non-small cell lung cancer patients: a multicenter real-world retrospective observational study (CTONG2004-ADV)
Chong-Rui Xu, Qixun Chen, Chengzhi Zhou, Lin Wu, Wen Li, Huizhong Zhang, Yongsheng Li, Fei Xu, Jianping Xiong, Qiming Wang, Haibo Zhang, Yuequan Jiang, Haitao Yin, Qingchen Wu, Qiangsheng Dai, Jian Hu, Jianhua Chen, Jian Zhang, Gang Wu, Jun Yin, Jianfu Zhao, Baogang Liu, Jianzhen Shan, Liming Sheng, Qunqing Chen, Zhengxiang Han, Huaqiu Shi, Yimin Liu, Jun Chen, Yi-Long Wu
Neoadjuvant pembrolizumab and chemotherapy in resectable clinical stage III non-small-cell lung cancer: a retrospective cohort study
Guangyin Zhao, Hongyu Zhang, Fengkai Xu, Chunlai Lu, Qiaoliang Zhu, Francesco Grossi, Duilio Divisi, Teng Ma, Jie Gu, Di Ge
A new preoperative localization of pulmonary nodules guided by mixed reality: a pilot study of an animal model
Ning Xin, Xiaoyu Wu, Zihao Chen, Rongqiang Wei, Yuichi Saito, Samy Lachkar, Alberto Salvicchi, Satoshi Fumimoto, Gabrielle Drevet, Zhifei Xu, Kenan Huang, Hua Tang